We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Alexandria & Lilly Unite at San Diego's One Alexandria Square
Read MoreHide Full Article
Key Takeaways
Alexandria and Eli Lilly launched Lilly Gateway Labs at One Alexandria Square in San Diego.
The new site builds on success of prior Gateway Labs in South San Francisco and Boston.
Biotech firms at the site focus on Alzheimer's, Parkinson's, cardiovascular, metabolic diseases and cancer.
Alexandria Real Estate Equities, Inc. (ARE - Free Report) recently announced the opening of Lilly Gateway Labs, powered by Alexandria, at the One Alexandria Square Megacampus in San Diego’s Torrey Pines.
Eli Lilly and Company first established Lilly Gateway Labs in 2019 in the San Francisco Bay Area, functioning as a shared innovation hub intended to support biotechnology companies in the development of life-changing medicines.
Lilly Gateway Labs in San Diego is a partnership between Lily and Alexandria. Alexandria provides top-class real estate infrastructure, facilities and lab operations, and placemaking acumen. Lilly brings scientific expertise, resources, mentorship, and access to capital through its venture network, including Alexandria Venture Investments.
This new San Diego lab builds on the success of Gateway Labs' first three U.S. sites in South San Francisco and Boston. These labs currently support the development of over 50 novel therapeutics and platforms. Gateway Labs San Diego aims to help its resident companies offer transformative treatments for patients around the world.
Alexandria started developing San Diego's life science ecosystem in 1994, with its first property acquired in Torrey Pines. The site of this property now anchors the newest phase of One Alexandria Square and is home to Lilly Gateway Labs. The Megacampus offers new amenities such as a grab-and-go café, a restaurant, an event lawn, meeting venues and a walking path. Its location is close to famous research institutions, giving One Alexandria Square tenants many chances to collaborate.
Lilly Gateway Labs San Diego opens with a group of biotech companies working on Alzheimer's, Parkinson's, cardiovascular and metabolic diseases and oncology. The new site facility features modular lab spaces with nearby collaboration areas, and advanced scientific amenities like microscopy and sequencing. The site also provides first-class operational support, strategic programming, and dedicated building security and concierge services.
Conclusion
Investors eyeing the life science and real estate sectors should take note of Alexandria's strategic move with Eli Lilly. The new opening of Gateway Labs in San Diego signifies a commitment to advancing innovation and supporting the growth of transformative medicines.
Over the past three months, shares of this Zacks Rank #3 (Hold) company have increased 15.4% compared with the industry’s growth of 1.7%.
The Zacks Consensus Estimate for SLG’s 2025 FFO per share has moved 83 cents northward to $6.21 over the past three months.
The Zacks Consensus Estimate for PLYM’s 2025 FFO per share has moved 2 cents upward to $1.88 over the past two months.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Alexandria & Lilly Unite at San Diego's One Alexandria Square
Key Takeaways
Alexandria Real Estate Equities, Inc. (ARE - Free Report) recently announced the opening of Lilly Gateway Labs, powered by Alexandria, at the One Alexandria Square Megacampus in San Diego’s Torrey Pines.
Eli Lilly and Company first established Lilly Gateway Labs in 2019 in the San Francisco Bay Area, functioning as a shared innovation hub intended to support biotechnology companies in the development of life-changing medicines.
Lilly Gateway Labs in San Diego is a partnership between Lily and Alexandria. Alexandria provides top-class real estate infrastructure, facilities and lab operations, and placemaking acumen. Lilly brings scientific expertise, resources, mentorship, and access to capital through its venture network, including Alexandria Venture Investments.
This new San Diego lab builds on the success of Gateway Labs' first three U.S. sites in South San Francisco and Boston. These labs currently support the development of over 50 novel therapeutics and platforms. Gateway Labs San Diego aims to help its resident companies offer transformative treatments for patients around the world.
Alexandria started developing San Diego's life science ecosystem in 1994, with its first property acquired in Torrey Pines. The site of this property now anchors the newest phase of One Alexandria Square and is home to Lilly Gateway Labs. The Megacampus offers new amenities such as a grab-and-go café, a restaurant, an event lawn, meeting venues and a walking path. Its location is close to famous research institutions, giving One Alexandria Square tenants many chances to collaborate.
Lilly Gateway Labs San Diego opens with a group of biotech companies working on Alzheimer's, Parkinson's, cardiovascular and metabolic diseases and oncology. The new site facility features modular lab spaces with nearby collaboration areas, and advanced scientific amenities like microscopy and sequencing. The site also provides first-class operational support, strategic programming, and dedicated building security and concierge services.
Conclusion
Investors eyeing the life science and real estate sectors should take note of Alexandria's strategic move with Eli Lilly. The new opening of Gateway Labs in San Diego signifies a commitment to advancing innovation and supporting the growth of transformative medicines.
Over the past three months, shares of this Zacks Rank #3 (Hold) company have increased 15.4% compared with the industry’s growth of 1.7%.
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks from the broader REIT sector are SL Green (SLG - Free Report) and Plymouth Industrial REIT (PLYM - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for SLG’s 2025 FFO per share has moved 83 cents northward to $6.21 over the past three months.
The Zacks Consensus Estimate for PLYM’s 2025 FFO per share has moved 2 cents upward to $1.88 over the past two months.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.